FDA Publishes Nanotechnology Draft Guidance
The agency is asking for public comment on what are its first steps towards better characterizing nanotechnology-related materials.
FDA on Thursday published its first draft guidance on nanomaterials. This is the agency’s first step towards informing interested parties on what characteristics could be considered when identifying commercial applications of nanotechnology.
The guidance, entitled “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology,” is available online and open for public comment.
Nanotechnology deals with materials smaller than 100 nanometers. Commercial interest in the technology has increased in recent years, with increased bioavailability of ingredients and greater efficacy with less material as potential benefits in food and dietary supplement industries.
Toxicology risks are intimately tied to the nanotechnology discussion (some of which have been outlined here) and, in 2006, FDA established the Nanotechnology Task Force to better understand such concerns.
“With this guidance, we are not announcing a regulatory definition of nanotechnology,” said Margaret A. Hamburg, MD, FDA commissioner of food and drugs. “However, as a first step, we want to narrow the discussion to these points and work with industry to determine if this focus is an appropriate starting place.”
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
